Therefore, it could be envisaged that under the conditions that exist in patients harboring prostate cancer, a substantial amount of α2M* is available to bind to cell surface GRP78 thus triggering mitogenic signaling and promoting cellular proliferation. The gene discussed is A2M; the disease is prostate cancer.